Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory

Amanda Cramer, Nigel Goodman, Timothy Cross, Vanya Gant, Magdalena Dziadzio
doi: https://doi.org/10.1101/2020.10.20.20215970

Article Information

doi 
https://doi.org/10.1101/2020.10.20.20215970
History 
  • October 21, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Amanda Cramer, MSc1,*,
  2. Nigel Goodman, MSc FIBMS CSci1,
  3. Timothy Cross, MSc1,
  4. Vanya Gant, PhD FRCP FRCPath1,2 and
  5. Magdalena Dziadzio, PhD FRCP FRCPath1,2
  1. 1Department of Immunology, HCA Healthcare UK, London, UK
  2. 2University College London
  1. ↵*corresponding author. Email address amanda.cramer{at}hcahealthcare.co.uk
Back to top
Posted October 21, 2020.
Download PDF
Data/Code
Email
Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory
Amanda Cramer, Nigel Goodman, Timothy Cross, Vanya Gant, Magdalena Dziadzio
medRxiv 2020.10.20.20215970; doi: https://doi.org/10.1101/2020.10.20.20215970
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area